Owlet, Inc.
NYSE:OWLTMedical - Devices
+$0.46 today
- Market cap
- $107.24M
- Beta
- 1.86
- P/E (TTM)
- -0.4
- EPS (TTM)
- -$12.67
Volume 0.64M
Average 0.24M
OWLT Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Owlet, Inc.NYSE: OWLT
Net Margin · Q1 FY2026 · quarter ended Mar 2026
Net margin narrows to -14.9%
Net margin was -14.9% in Q1 FY2026, down 29.2 pp from a year earlier. On a trailing-twelve-month basis it was -43.0%, down 27.9 pp year over year. Over 3 fiscal years it widened by 77.1 pp.
Context
- Net margin widened in 2 of the last 3 fiscal years.
What to watch
Whether net margin reaches the consensus estimate from 3 analysts of -5.8% for the fiscal year ending Dec 2026, up from -37.5% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -14.9%+19.8 pp QoQ
- Last fiscal yearDec 2025
- -37.5%-21.5 pp YoY
- LTMMar 2026
- -43.0%-27.9 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -29.2 pp | +136.1 pp | +165.2 pp |
| 1 year | -21.5 pp | +31.7 pp | +53.2 pp |
| 3 years | +77.1 pp | +39.8 pp | -37.3 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -37.5%
- Year-over-year change
- -21.5pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -37.5% | -21.5pp |
| FY2024 | 2024-12-31 | -16.1% | +44.9pp |
| FY2023 | 2023-12-31 | -60.9% | +53.7pp |
| FY2022 | 2022-12-31 | -114.6% | -20.1pp |
| FY2021 | 2021-12-31 | -94.5% | — |
Net Margin vs competitors
How OWLT compares with its peers on the latest reported figures
- OWLT's LTM Mar 2026 net margin of -43.0% is the 3rd highest of the 8 companies compared; the peer median is -145.8%.
- Its year-over-year change of -27.9 pp is the 6th highest of 8, against a peer median of +5.4 pp.
- Over three fiscal years its change of +77.1 pp compares with a peer median of +3.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Mar 2026 | 50.9% | +150.1 pp | -2.3 pp | |
| LTM Mar 2026 | -9.5% | +50.6 pp | +3.4 pp | |
| LTM Mar 2026 | -43.0% | -27.9 pp | +77.1 pp | |
| LTM Mar 2026 | -121.2% | -10.2 pp | -81.9 pp | |
| LTM Mar 2026 | -145.8% | +5.4 pp | +214.6 pp | |
| LTM Mar 2026 | -876.7% | +604.8 pp | +13666.8 pp | |
AVRAnteris Technologies Global Corp. | LTM Mar 2026 | -5148.8% | -1866.9 pp | -3966.4 pp |
| LTM Mar 2026 | -8526.1% | -217.6 pp | +2294.9 pp | |
| FY2025 | — | — | — | |
ELTXElicio Therapeutics, Inc. | FY2025 | — | — | — |
| Peer median (excluding OWLT) | -145.8% | +5.4 pp | +3.4 pp | |
Competitors are the stored peer set for OWLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 75.84M | 69.2M | 54.01M | 78.06M | 105.71M |
| Cost of Revenue | 40.78M | 45.89M | 31.42M | 38.75M | 52.18M |
| Gross Profit | 35.06M | 23.31M | 22.59M | 39.31M | 53.53M |
| Gross Margin | 46.2% | 33.7% | 41.8% | 50.4% | 50.6% |
| Research & Development | 21.43M | 27.9M | 10.35M | 9.8M | 14.08M |
| Selling, General & Admin | 69.42M | 80.04M | 40.87M | 49.73M | 47.72M |
| Operating Expenses | 90.85M | 107.93M | 51.22M | 59.53M | 61.79M |
| Depreciation & Amortization | 1.13M | 2.67M | 2.21M | 1.38M | 590K |
| EBITDA | (42.71M) | (75.53M) | (27.49M) | (9.47M) | (35.64M) |
| EBITDA Margin | -56.3% | -109.1% | -50.9% | -12.1% | -33.7% |
| Operating Income | (55.79M) | (84.62M) | (28.63M) | (20.22M) | (8.26M) |
| Operating Margin | -73.6% | -122.3% | -53.0% | -25.9% | -7.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 27.83M | 1.1M | 3.19M | 1.63M | 3.42M |
| Other Income / Expenses | (15.88M) | 5.31M | (4.26M) | 7.74M | (31.39M) |
| Income Before Tax | (71.67M) | (79.31M) | (32.89M) | (12.48M) | (39.65M) |
| Pre-Tax Margin | -94.5% | -114.6% | -60.9% | -16.0% | -37.5% |
| Income Tax Expense | 31K | 29K | 10K | 54K | 28K |
| Net Income | (71.7M) | (79.34M) | (32.9M) | (12.54M) | (39.68M) |
| Net Margin | -94.5% | -114.6% | -60.9% | -16.1% | -37.5% |
| EPS (Basic) | (12.47) | (9.97) | (4.53) | (0.83) | (2.24) |
| EPS (Diluted) | (12.47) | (9.97) | (4.53) | (0.83) | (2.24) |
| Weighted Avg Shares | 7.87M | 7.95M | 8.28M | 15.11M | 562.5M |
| Weighted Avg Shares (Diluted) | 7.87M | 7.95M | 8.28M | 15.11M | 562.5M |
Owlet, Inc.
NYSE:OWLT
Intrinsic Alpha fair value
Locked
Current Price
$3.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.